Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

7-Hydroxy Ondansetron (HCl Salt)

● In Stock

Catalogue No.:	VE0018486
CAS No.:	N/A
Mol. Formula:	C18H19N3O2. HCl
Mol. Weight:	309.37 36.46 g/mol

Request a quote

Add to RFQ list

Additional information on 7-Hydroxy Ondansetron (HCl Salt)

Parent drug

Ondansetron

IUPAC Name

7-hydroxy-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1, 2, 3, 9-tetrahydro-4H-carbazol-4-one, hydrochloride (1:1)

Synonyms

N/A

Smiles

O=C1C(CN2C=CN=C2C)CCC(N3C)=C1C4=C3C=C(O)C=C4.[H]Cl

InChI

InChI=1S/C18H19N3O2.ClH/c1-11-19-7-8-21(11)10-12-3-6-15-17(18(12)23)14-5-4-13(22)9-16(14)20(15)2;/h4-5,7-9,12,22H,3,6,10H2,1-2H3;1H

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

The compound 7-Hydroxy Ondansetron (HCl Salt) is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Ondansetron production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.